The Boardroom Report — Wednesday, July 22, 2026

The administration’s appointment of a vocal critic to lead federal antitrust efforts, coupled with a sudden legal injunction against a major industry merger, signals a significant escalation in the regulatory risks facing corporate consolidation.

Good morning. 8 developments for the boardroom today — one story in full below, then 7 more for subscribers.

The resurgence of public equity markets and traditional investment banking activity has decoupled from the performance of private capital, reversing a multi-year trend of private-sector dominance. Goldman Sachs and JPMorgan Chase reported investment banking revenue increases of 21% and 50% respectively in the most recent quarter, driven by a recovery in initial public offerings and debt underwriting. Conversely, private equity exit volumes remain 30% below their five-year historical average, as the gap between seller expectations and the cost of acquisition financing persists despite the stabilization of benchmark interest rates under the Trump administration.

For board directors and C-suite executives, this shift necessitates a recalibration of capital allocation strategies and a reassessment of exit pathways. The relative attractiveness of public listings over private secondary sales alters the cost-of-capital calculus for mid-market firms and portfolio companies. Governance structures must now account for a heightened regulatory focus on private fund valuations and liquidity mismatches, particularly as institutional investors rebalance portfolios toward liquid public equities. Firms relying on private credit must evaluate the sustainability of their leverage ratios if the current premium over public high-yield debt continues to widen.

Monitor the Federal Reserve’s September policy meeting for signals on the terminal rate, as any deviation from the projected 4.25% floor will dictate whether the current IPO momentum translates into a sustained cycle of large-scale corporate M&A.

→ Financial Times

Today’s briefing examines how shifting antitrust enforcement priorities and evolving trade policies are fundamentally altering the risk landscape for cross-border operations and large-scale M&A. As market expectations for long-term inflation decouple from central bank targets, boards must reassess capital allocation strategies and pricing models to maintain resilience. Failure to account for these regulatory and macroeconomic pivots may leave organizations exposed to significant litigation and strategic misalignment.